Key Takeaways Tesamorelin has FDA approval backed by two Phase 3 RCTs showing roughly 15 to 18 percent visceral fat reduction at 26 weeks in HIV-lipodystrophy patients (Falutz et al., 2007, 2010)
Patients often experience reduced hunger, but regular eating is still crucial
By improving the skins internal health, you enhance the longevity and quality of your external cosmetic results
[90] enrolled 11 severely obese T2D patients, treated them with either exenatide twice-daily (nine patients) or liraglutide (two patients) for 6 months, and compared the carotid IMT before and after the GLP-1 RA treatment
But heres where libido can enter the equation: These medications reduce dopamine-driven reward signaling the same system that drives food cravings, pleasure, and motivation
Further research is warranted to explore its full benefit on outcomes in this setting